Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan. [PDF]
J Am Soc Nephrol, 2020 Akizawa T +4 more
europepmc +1 more source
Long-Term Safety and Efficacy of JR-131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study. [PDF]
Ther Apher Dial, 2020 Nishi S +4 more
europepmc +1 more source
Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers. [PDF]
BioDrugs, 2019 Kim S, Hong T, Ko JW, Huh W, Kim JR.
europepmc +1 more source
Corrigendum: Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase III trial. [PDF]
Chronic Dis Transl Medeuropepmc +1 more source
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents. [PDF]
Blood Res, 2018 Lee SE +12 more
europepmc +1 more source
Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial. [PDF]
BMC Nephrol, 2019 Sinha SD +9 more
europepmc +1 more source
APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania. [PDF]
Memo, 2018 Berbec NM +7 more
europepmc +1 more source
A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease. [PDF]
Can J Kidney Health DisSaini R +7 more
europepmc +1 more source
Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy. [PDF]
Front NeurolSun Y, Song B, Zhang Y, Zhang Y, Zhou L.
europepmc +1 more source